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Density mediated drug release from 
dapivirine vaginal rings produced by 
additive manufacturing
Background
Objectives
Methods
Droplet deposition modelling (DDM) is a form of 3D printing that
fuses droplets of molten polymer to create each layer, providing
exquisite levels of control over an object’s design and morphology.
Such manipulation allows properties including density, geometry and
surface area to be manipulated in ways that have been unthinkable
using conventional thermoplastic processing techniques. Here we
utilise the DDM process and compare this to injection moulding (IM)
to produce dapivirine (DPV) loaded vaginal rings using a
pharmaceutically relevant, life science grade thermoplastic
polyurethane.
Identify grades of TPU which are compatible with both additive
manufacturing (DDM) and traditional manufacturing processes (IM).
• Thermoplastic polymers should have ≤2% weight loss at
processing temperature as assessed by TGA.
Compound filament with 10% w/w DPV and pelletise to produce
pellets ~2.0 mm.
Compare drug delivery and other physiochemical properties of
vaginal drug delivery devices fabricated by additive manufacturing
(DDM) against conventional manufacturing techniques (IM).
Vaginal rings (54.0 mm outer diameter, 4.0 mm cross sectional
diameter) were fabricated by injection molding or Arburg Plastic
Freeforming – a proprietary DDM process, using a hydrophobic TPU
(T87 or T60) loaded with 10% w/w dapivirine. Using the DDM
process, rings of 100, 50 and 10% matrix density were produced.
Rings were evaluated for in vitro drug release over 29 days in an
aqueous release media and assessed for thermal characteristics.
Results
DDM printing on an Arburg Freeformer has provided 
a new potential to either increase the release rate of 
poorly water soluble compounds or reduce the 
loading required to maintain a desired release rate.
VRs with an infill density of 100% manufactured by 
IM and DDM released up to 4 and 10% of their total 
DPV loading, while rings with an infill density of 50 or 
10% (DDM) released up to 56 and 79% of their total 
DPV loading after 29 days.
Key points
DDM printing on an Arburg Freeformer has been 
shown to create vaginal rings with a range of 
densities.
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Fig. 2: DSC thermal trace for model drug (DPV), DPV 
loaded (10% w/w) T87 and T60 filament (n=3, 
representative data shown). Samples were heated from 
either -90°C or -50°C to 250°C at a rate of 20°C min-1.
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Fig. 1: Diagram of Arburg Freeformer and internal 
components.
Fig. 4: Digital images showing the base of a quarter of T87-DPV VRs (outer diameter 54.00 mm,
cross-sectional diameter 4.00 mm) fabricated by droplet deposition modelling with an infill density of
(1) 100%, (2) 50% and (3) 10%.
1
A21 2 3
Fig. 3: (A) Daily (Mean ± SD, n=6) and (B) Cumulative 
release (n=6) of DPV from T87-DPV vaginal rings 
(outer diameter 54.00 mm, cross-sectional diameter 
4.00 mm, fabricated by injection molding (IM) or droplet 
deposition modelling (DDM) with densities of 10% 
(R10), 50% (R50) or 100% (R100). In-vitro release was 
performed in a 0.2% tween solution.
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Fig. 5: Cumulative release plotted as a percentage of the total drug loading in each of the vaginal
ring types (n=6) of DPV from T87-DPV vaginal rings (outer diameter 54.00 mm, cross-sectional
diameter 4.00 mm, fabricated by injection molding (IM) or droplet deposition modelling (DDM) with
densities of 10%, 50% or 100%. In-vitro release was performed in a 0.2% tween solution. The ring
photographs indicate the density and total drug loading (mg) for each type of ring.
Table 1: Dimensional analysis of DDM printed VRs (n=6) manufactured using T87-DPV or T60- DPV
